Completion of radiotherapy is associated with the Vulnerable Elders Survey-13 score in elderly patients with cancer

被引:43
作者
Spyropoulou, Despina [1 ]
Pallis, Athanasios G. [2 ]
Leotsinidis, Michail [3 ]
Kardamakis, Dimitrios [1 ]
机构
[1] Univ Patras, Sch Med, Dept Radiat Oncol, GR-26110 Patras, Greece
[2] Univ Gen Hosp Heraklion, Dept Med Oncol, Iraklion, Greece
[3] Univ Patras, Sch Med, Dept Publ Hlth, GR-26110 Patras, Greece
关键词
Vulnerable Elders Survey-13; Elderly; Cancer; Radiotherapy; COMPREHENSIVE GERIATRIC ASSESSMENT; FUNCTIONAL DECLINE; OLDER-PEOPLE; CARE; UNDERTREATMENT; PARTICIPATION; DISABILITY; MORTALITY; OUTCOMES; QUALITY;
D O I
10.1016/j.jgo.2013.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Vulnerability assessment of geriatric patients with cancer may contribute to improved anti-cancer treatment with maximal results and minimal side effects. The aim of the present study was to evaluate whether the Vulnerable Elders Survey-13 (VES-13) score is associated with completion of radiotherapy among elderly patients with cancer. Materials and Methods: This was a prospective observational study that included patients greater than age 75 with histologically confirmed cancer disease, referred to the Department of Radiation Oncology to receive radical or palliative radiotherapy, from 2010 to 2012. VES-13 forms were filled in before the initiation of radiotherapy and scores were assigned according to a standardized scoring procedure. Results: Of a total of 230 participants (median age 78.5 years), 41 (17.8%) did not complete radiotherapy. These patients had higher VES-13 scores (median with interquartile range: 5 [2-8.5]) compared to those who completed the treatment (3 [1-7]; P = 0.008). A VES-13 score > 3 was associated with 2.14 times higher probability of not completing radiotherapy, whereas in patients with scores > 7 this probability was 3.34 times higher. The association between higher VES-13 scores and non-completion of radiotherapy was independent of other factors, such as age, sex, comorbidities, type of radiotherapy, and presence of side effects. Conclusion: Patients with higher VES-13 scores had increased probability of not completing radiotherapy in our study, and this effect was independent of other factors that might affect radiotherapy completion. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 27 条
[1]   Using assessing care of vulnerable elders quality indicators to measure quality of hospital care for vulnerable elders [J].
Arora, Vineet M. ;
Johnson, Martha ;
Olson, Jared ;
Podrazik, Paula M. ;
Levine, Stacie ;
DuBeau, Catherine E. ;
Sachs, Greg A. ;
Meltzer, Anddavid O. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (11) :1705-1711
[2]   The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer [J].
Asadauskiene, Jolita ;
Aleknavicius, Eduardas ;
Zelviene, Terese Pipiriene ;
Jankevicius, Feliksas .
MEDICINA-LITHUANIA, 2010, 46 (05) :305-314
[3]  
Balducci Lodovico, 2005, J Oncol Manag, V14, P47
[4]   Undertreatment strongly decreases prognosis of breast cancer in elderly women [J].
Bouchardy, C ;
Rapiti, E ;
Fioretta, G ;
Laissue, P ;
Neyroud-Caspar, I ;
Schäfer, P ;
Kurtz, J ;
Sappino, AP ;
Vlastos, G .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3580-3587
[5]  
Giannakouris K., 2008, STAT FOCUS, V2008, P72
[6]   Underrepresentation of patients 65 years of age or older in cancer-treatment trials. [J].
Hutchins, LF ;
Unger, JM ;
Crowley, JJ ;
Coltman, CA ;
Albain, KS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (27) :2061-2067
[7]   Barriers to clinical trial participation by older women with breast cancer [J].
Kemeny, MM ;
Peterson, BL ;
Kornblith, AB ;
Muss, HB ;
Wheeler, J ;
Levine, E ;
Bartlett, N ;
Fleming, G ;
Cohen, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) :2268-2275
[8]   Clinical Evidence on the Undertreatment of Older and Poor Performance Patients Who Have Advanced Non-Small-Cell Lung Cancer: Is There a Role for Targeted Therapy in These Cohorts? [J].
Langer, Corey J. .
CLINICAL LUNG CANCER, 2011, 12 (05) :272-279
[9]   Participation of patients 65 years of age or older in cancer clinical trials [J].
Lewis, JH ;
Kilgore, ML ;
Goldman, DP ;
Trimble, EL ;
Kaplan, R ;
Montello, MJ ;
Housman, MG ;
Escarce, JJ .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1383-1389
[10]   OUTCOMES OF CHEMORADIOTHERAPY IN CERVICAL CANCER-THE WESTERN AUSTRALIAN EXPERIENCE [J].
Lim, Adeline ;
Sia, Serena .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04) :1431-1438